We will be glad to help and assist you in finding the crossword clues for the following clue: Relinquish.
looking at this crossword definition, it has 10 letters.
for better and easier way of searching the for a crossword clue, try using the search term “Relinquish crossword” or “Relinquish crossword clue” while searching and trying to find help in finishing your crosswords. Here are the possible answers for Relinquish.
We hope you found what you needed!
If you are still unsure with some definitions, don’t hesitate to search for them here in our site using the search box on top.
Possible Answers:
CEDE.
Last seen on: USA Today Crossword – Jan 7 2023
Random information on the term “Relinquish”:
Prosthetic Records is an American record label specializing in heavy metal recordings, founded in Los Angeles, California in 1998 by E.J. Johantgen and Dan Fitzgerald. Prosthetic Records released the first two albums by Lamb of God and Animals as Leaders and was the North American home to Gojira and are currently home to .gif from god, Dawn Ray’d, Thotcrime, Vile Creature, Psycroptic, Four Stroke Baron and many more artists.
Random information on the term “CEDE”:
Thorotrast is a suspension containing particles of the radioactive compound thorium dioxide, ThO2; it was used as a radiocontrast agent in clinical radiography in the 1930s to 1950s. It is no longer used clinically.
Thorium compounds produce excellent images because of thorium’s high opacity to X-rays (it has a high cross section for absorption). However, thorium is retained in the body, and it is radioactive, emitting harmful alpha radiation as it decays. Because the suspension offered high image quality and had virtually no immediate side-effects compared to the alternatives available at the time, Thorotrast became widely used after its introduction in 1931. António Egas Moniz contributed to its development. About 2 to 10 million patients worldwide have been treated with Thorotrast. However, today it has shown an increase risk in certain cancers such as cholangiocarcinomas, angiosarcomas, hepatocellular carcinoma and hepatic fibrosis of the liver.
Even at the time of introduction, there was concern about the safety of Thorotrast. Following injection, the drug is distributed to the liver, spleen, lymph nodes, and bone, where it is absorbed. After this initial absorption, redistribution takes place at a very slow pace. Specifically, the biological half-life is estimated to be 22 years. This means that the organs of patients who have been given Thorotrast will be exposed to internal alpha radiation for the rest of their lives. The significance of this long-term exposure was not fully understood at the time of Thorotrast’s introduction in 1931.